10Z-Hymenialdisine is primarily studied for its potential in biomedical research, particularly in the field of cancer therapy. It exhibits inhibitory effects on various kinases, which are enzymes that play a critical role in cell signaling and cancer progression. This compound is being explored for its ability to disrupt pathways involved in tumor growth and survival, making it a candidate for developing targeted cancer treatments. Additionally, its anti-inflammatory properties are of interest for treating conditions where inflammation is a key factor, such as arthritis or neurodegenerative diseases. Research is ongoing to further understand its mechanisms and optimize its therapeutic applications.